Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Aug;33(8):1738-40.
doi: 10.2337/dc09-2256.

Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin

Hugh D Tildesley  1 , Adel B Mazanderani, Stuart A Ross
Affiliations
Randomized Controlled Trial

Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin

Hugh D Tildesley et al. Diabetes Care. 2010 Aug.

Abstract

Objective: To assess the effect of an Internet-based glucose monitoring system (IBGMS) on A1C levels in patients with type 2 diabetes treated with insulin.

Research design and methods: This trial involved 50 patients randomly assigned to receive either conventional treatment alone or with additional follow-up through an IBGMS for 6 months. Patients randomized to the intervention group uploaded blood glucose readings every 2 weeks to a secure Web site for review and receipt of feedback from their endocrinologist. A1C and laboratory test results were collected at 0, 3, and 6 months.

Results: The baseline parameters were not significantly different. Over a 6-month follow-up, A1C dropped from 8.8 to 7.6% (P < 0.001) in the intervention group compared with 8.5 to 8.4% (P = 0.51) in the control group.

Conclusions: The use of IBGMS significantly improved A1C levels in patients with type 2 diabetes treated with insulin.

Trial registration: ClinicalTrials.gov NCT00814190.

PubMed Disclaimer

References

    1. Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc 2007;82:229–236 - PubMed
    1. Austin MM, Haas L, Johnson T, Parkin CG, Parkin CL, Spollett G, Volpone MT. Self-monitoring of blood glucose: benefits and utilization. Diabetes Educ 2006;32:835–836, 844–847 - PubMed
    1. Nielsen JK, Christiansen JS. Self-monitoring of blood glucose—epidemiological and practical aspects. Diabetes Technol Ther 2008;10:S35–S42
    1. American Diabetes Association. Standards of medical care in diabetes—2008 (Position Statement). Diabetes Care 2008;31:S12–S54 - PubMed
    1. Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol 2008;2:1030–1053 - PMC - PubMed

Publication types

Associated data